DK1493435T3 - Sammensætning af betahistin med styret frigivelse - Google Patents

Sammensætning af betahistin med styret frigivelse

Info

Publication number
DK1493435T3
DK1493435T3 DK03015172T DK03015172T DK1493435T3 DK 1493435 T3 DK1493435 T3 DK 1493435T3 DK 03015172 T DK03015172 T DK 03015172T DK 03015172 T DK03015172 T DK 03015172T DK 1493435 T3 DK1493435 T3 DK 1493435T3
Authority
DK
Denmark
Prior art keywords
controlled release
betahistine
optionally
coating layer
composition
Prior art date
Application number
DK03015172T
Other languages
English (en)
Inventor
Flavio Fossati
Anna Perachiotti
Marco Carnaghi
Luciano Marcelloni
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of DK1493435T3 publication Critical patent/DK1493435T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03015172T 2003-07-04 2003-07-04 Sammensætning af betahistin med styret frigivelse DK1493435T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03015172A EP1493435B1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Publications (1)

Publication Number Publication Date
DK1493435T3 true DK1493435T3 (da) 2008-09-08

Family

ID=33427119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03015172T DK1493435T3 (da) 2003-07-04 2003-07-04 Sammensætning af betahistin med styret frigivelse

Country Status (17)

Country Link
EP (1) EP1493435B1 (da)
CN (1) CN1816323A (da)
AT (1) ATE395048T1 (da)
CY (1) CY1108551T1 (da)
DE (1) DE60320965D1 (da)
DK (1) DK1493435T3 (da)
EA (1) EA011569B1 (da)
EC (1) ECSP066267A (da)
ES (1) ES2306827T3 (da)
GE (1) GEP20084349B (da)
LT (1) LT5379B (da)
MX (1) MXPA06000090A (da)
PL (1) PL379374A1 (da)
PT (1) PT1493435E (da)
SI (1) SI1493435T1 (da)
TN (1) TNSN05326A1 (da)
WO (1) WO2005004850A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CN102046170B (zh) 2008-05-27 2012-11-28 墨尔本大学 治疗患有咽鼓管功能障碍的哺乳动物的方法
DE102012105528A1 (de) * 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
ES2862209T3 (es) 2017-07-20 2021-10-07 Intas Pharmaceuticals Ltd Composiciones orales sólidas de liberación prolongada no pulsátil que contienen betahistina
CN111249237A (zh) * 2019-12-21 2020-06-09 乐普恒久远药业有限公司 盐酸倍他司汀药物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (da) 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
IT1229237B (it) 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
GB9104854D0 (en) * 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
IT1309591B1 (it) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.

Also Published As

Publication number Publication date
PT1493435E (pt) 2008-08-14
PL379374A1 (pl) 2006-09-04
GEP20084349B (en) 2008-04-10
CN1816323A (zh) 2006-08-09
DE60320965D1 (de) 2008-06-26
CY1108551T1 (el) 2014-04-09
EA011569B1 (ru) 2009-04-28
ECSP066267A (es) 2006-07-28
ES2306827T3 (es) 2008-11-16
LT5379B (lt) 2006-10-25
ATE395048T1 (de) 2008-05-15
EA200501908A1 (ru) 2006-08-25
TNSN05326A1 (en) 2007-07-10
EP1493435B1 (en) 2008-05-14
MXPA06000090A (es) 2006-04-07
WO2005004850A1 (en) 2005-01-20
EP1493435A1 (en) 2005-01-05
LT2006009A (en) 2006-06-27
SI1493435T1 (sl) 2008-10-31

Similar Documents

Publication Publication Date Title
CY1108551T1 (el) Ελεγχομενης απελευθερωσης συνθεσεις της βεταϊστινης
BRPI0411548A (pt) stent polimérico e método de fabricação
ATE386509T1 (de) Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
BR0002880A (pt) Composição farmacêutica de liberação controlada termoformável sólida
DE60326275D1 (de) Polymilchsäurepolymerzusammensetzung zum thermoformen, polymilchsäurepolymerflächengebilde zum thermoformen und thermogeformtergegenstand daraus
BR0207871A (pt) Composição para liberar bisfosfonato para um alvo
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
ATE273745T1 (de) Verfahren zur herstellung aktivstoffhaltiger kapseln mit ultradünner wandschicht
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
BRPI0509194A (pt) formulação e método de comprimido revestido
IT1298574B1 (it) Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
ATE352290T1 (de) Wärmeformbare feste pharmazeutische zusammensetzung für die kontrollierte freigabe von ivabradin
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
ATE418969T1 (de) Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung
CY1111666T1 (el) Απο του στοματος συνθεση ανυδρης ολανζαπινης μορφης 1
BR0008739A (pt) Composições de liberação controlada debeta-histina
IT1320211B1 (it) Polimeri organici antiriflettenti per rivestimenti e loro procedimentodi preparazione.
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
SE0001916D0 (sv) Novel formulation
DK1265856T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf
FR2791349B1 (fr) Composition decapante, utilisable notamment dans le domaine du batiment
ATE369842T1 (de) Zusammensetzungen mit schneller freisetzung enthaltend cefuroxime axetil
AR072810A1 (es) Compuesto de 3-( 4 fenilsulfonil-1-piperazinil) carbonil) pirazolo(1,5 -a) pirimidina , composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento para el tratamiento del dolor.
GB2424185A (en) Cough mixture comprising codeine linctus and guaifenesin